HR

Healthcare Realty Trust Announces Dividend as Shares Tumbles

Healthcare Realty Trust Incorporated (NYSE: HR) has announced a cash dividend of $0.31 per share on its common stock, payable on March 14, 2024, to class A common stockholders of record on February 26, 2024. Ron Hubbard, Vice President of Investor Relations, stated, "We are pleased to announce our quarterly dividend, reflecting our commitment to delivering value to our shareholders."

In addition to the common stock dividend, eligible holders of the company's operating partnership units will receive an op unit distribution of $0.31 per unit, equivalent to the common stock dividend.

Healthcare Realty Trust is a real estate investment trust that specializes in owning and operating medical outpatient buildings primarily located around market-leading hospital campuses. The company's portfolio includes nearly 700 properties totaling over 40 million square feet concentrated in 15 growth markets.

The company's shares have experienced a -3.4% movement, currently trading at a price of $15.22.

When asked about the market outlook, Hubbard added, "We remain optimistic about the opportunities in the healthcare real estate sector and are focused on selectively growing our portfolio through property acquisition and development."

The full 8-K submission from Healthcare Realty Trust Incorporated is available here.

2018 2019 2020 2021 2022 2023
Revenue (MM) $696 $692 $500 $535 $933 $1,351
Revenue Growth n/a -0.63% -27.8% 7.04% 74.38% 44.9%
Net Margins 31% 4% 14% 12% 4% -20%
Net Income (MM) $213 $30 $72 $67 $41 -$273
Net Interest Expense (MM) $103 $97 $56 $53 $147 $260
Depreciation & Amort. (MM) $280 $290 $190 $203 $453 $736
Earnings Per Share $2.03 $0.29 $0.54 $0.47 $0.16 -$0.72
EPS Growth n/a -85.71% 86.21% -12.96% -65.96% -550.0%
Diluted Shares (MM) 105 105 134 143 254 379
Free Cash Flow (MM) $260 $249 $395 $135 $109 $296
Capital Expenditures (MM) $78 $92 $75 $97 $164 $223
Total Debt (MM) $2,541 $2,750 $3,027 $1,801 $5,352 $5,227
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS